Drugs.com Blog

The Official Drugs.com Blog

Q1 2013 Drug Sales Data Released: Rough U.S Flu Season Boosts Numbers for Tamiflu

May 5, 2013 By Drugs.com

The latest U.S. drug sales data has been released by Drugs.com. The top five drugs have minor shifts in rank but exhibit positive growth for Q1 2013. Abilify, Otsuka’s second generation antipsychotic, and Nexium, AstraZeneca’s leading acid blocker, rank as the top two drugs by sales for the fourth quarter in a row. Both agents hover in the $1.5 billion range for quarterly sales. In addition, the Tamiflu statistics show that the most recent U.S. flu season hit long and hard.

View the data here…
https://www.drugs.com/stats/top100/sales

Filed Under: Media, Statistics

Recent Posts

  • Saturday, April 28, 2018 is National Prescription Drug Take-Back Day April 23, 2018
  • New Drugs.com Compare Tool March 28, 2018
  • Drugs.com Receives eHealthcare Leadership Silver Award October 29, 2017
  • Drugs.com Recognized as ‘Health Information Website Brand of the Year’ in 2017 Harris Poll EquiTrend® Study May 9, 2017
  • REMS@FDA: An Upgraded Patient Safety Program July 26, 2016

Categories

  • Business
  • Commentary
  • Media
  • Mobile
  • Patient Safety
  • Site Upgrades
  • Statistics
  • Uncategorized

Copyright © 2018 Drugs.com - Return to Drugs.com